Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 724 | 893 | 784 | 952 | 393 |
| Gross Profit | 724 | 893 | 784 | 952 | 393 |
| Operating Expenses | 1,447 | 2,445 | 1,646 | 1,647 | 1,674 |
| Operating Income | -723 | -1,552 | -862 | -695 | -1,281 |
| Interest Expense | 0 | 0 | 3 | 2 | 0 |
| Other Income | 826 | 972 | 915 | 1,242 | 613 |
| Pre-tax Income | 103 | -580 | 50 | 545 | -668 |
| Income Tax | N/A | N/A | N/A | N/A | -32 |
| Net Income Continuous | 103 | -612 | 50 | 545 | -636 |
| Net Income Discontinuous | -8 | -7 | 102 | 6 | -17 |
| Net Income | $95 | $-619 | $152 | $551 | $-653 |
| EPS Basic Total Ops | 0.01 | -0.05 | 0.01 | 0.05 | -0.06 |
| EPS Basic Continuous Ops | 0.01 | -0.05 | 0.00 | 0.05 | -0.06 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.01 | -0.05 | 0.01 | 0.05 | -0.06 |
| EPS Diluted Continuous Ops | 0.01 | -0.05 | 0.00 | 0.05 | -0.06 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.01 | N/A | 0.00 | 0.05 | -0.06 |
| EBITDA(a) | $-398 | $-646 | $-766 | $-753 | $-1,032 |